Literature DB >> 12670702

Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes.

S Sayah1, A C Jauneau, C Patte, M C Tonon, H Vaudry, M Fontaine.   

Abstract

C3a and C5a anaphylatoxins are two proinflammatory peptides generated during complement system activation. C3a and C5a exert several biological activities through binding to their specific receptors, named C3aR and C5aR, respectively. We have previously shown that C3aR and C5aR are constitutively expressed by astrocytes, a cell type that actively participates in inflammatory events in the central nervous system. In this article, we focus on the transduction signal pathways activated by these two receptors on astrocytes. We show that the stimulation of C3aR or C5aR results in the activation of the mitogen activated protein kinase pathway by phosphorylation of the p44 and p42 kinases. On the contrary, the binding of C3a or C5a to their receptors on astrocytes decreases the production of cAMP, revealing an inhibition of the adenylyl cyclase pathway. Stimulation of C3aR and C5aR induces an increase in intracellular calcium concentration, arising from the opening of intracellular calcium channels. The observed calcium wave results from the activation of the phospholipase C pathway. Taken together, our results suggest that the binding of C3a or C5a to their receptors on astrocytes would be of functional importance since it induces the activation of two important transduction pathways leading to several cellular events such as neurotrophin and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670702     DOI: 10.1016/s0169-328x(03)00046-9

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  23 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

Review 2.  Complementing the inflammasome.

Authors:  Martha Triantafilou; Timothy R Hughes; Bryan Paul Morgan; Kathy Triantafilou
Journal:  Immunology       Date:  2016-02       Impact factor: 7.397

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

4.  Complement Peptide C3a Promotes Astrocyte Survival in Response to Ischemic Stress.

Authors:  Noriko Shinjyo; Yolanda de Pablo; Milos Pekny; Marcela Pekna
Journal:  Mol Neurobiol       Date:  2015-05-14       Impact factor: 5.590

5.  CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model.

Authors:  Sarah A Ingersoll; Carol B Martin; Scott R Barnum; Brian K Martin
Journal:  Mol Immunol       Date:  2010-09-01       Impact factor: 4.407

6.  The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.

Authors:  Ching-Chuan Hsieh; Hong-Shiue Chou; Horng-Ren Yang; Feng Lin; Sumantha Bhatt; Jie Qin; Lianfu Wang; John J Fung; Shiguang Qian; Lina Lu
Journal:  Blood       Date:  2013-01-08       Impact factor: 22.113

7.  Complement C3a regulates Muc5ac expression by airway Clara cells independently of Th2 responses.

Authors:  Patricia Dillard; Rick A Wetsel; Scott M Drouin
Journal:  Am J Respir Crit Care Med       Date:  2007-03-30       Impact factor: 21.405

8.  C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.

Authors:  Lu Liu; Ying Zhang; Ximei Duan; Qi Peng; Quan Liu; Yali Zhou; Songxia Quan; Guolan Xing
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

9.  Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum.

Authors:  Elena Del Tordello; Irene Vacca; Sanjay Ram; Rino Rappuoli; Davide Serruto
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

10.  C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus.

Authors:  Supriya D Mahajan; Neil U Parikh; Trent M Woodruff; James N Jarvis; Molly Lopez; Teresa Hennon; Patrick Cunningham; Richard J Quigg; Stanley A Schwartz; Jessy J Alexander
Journal:  Immunology       Date:  2015-07-15       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.